CESAR
MORIS DE LA TASSA
Catedrático de Universidad
Vicente
Mainar
Publications dans lesquelles il/elle collabore avec Vicente Mainar (5)
2022
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958
2010
-
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
Circulation, Vol. 121, Núm. 10, pp. 1176-1187
2005
-
Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease
International Journal of Cardiology, Vol. 98, Núm. 3, pp. 479-486